Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Department of Health and Human Services ▸ National Institutes of Health
Description
The National Institute on Aging is offering grant opportunities for small businesses through its STTR program. The goal is to support research aimed at developing innovative products or services to prevent or treat Alzheimer's disease and related dementias, or to improve care for patients with these conditions.
This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Technology Transfer Research (STTR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services with the pote…
Source
Grant ID
PAS-22-197
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Small businesses
Awards & Funding
Award Ceiling
$1.8M
Funding Amount
Discretionary
Links
Similar opportunities
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
- Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials
- Notice of Special Interest (NOSI): Administrative Supplements for NIA-VA Mentored Physician and Clinical Psychologist Scientist Award in Alzheimers Disease (AD) and AD-Related Dementias (ADRD)
- NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)
- Notice of Special Interest (NOSI): Novel Approaches to Characterizing and Diagnosing Alzheimer's Disease and Related Dementias